Go Pro

CareTrust REIT (CTRE) Financials

CareTrust REIT logo
$39.71 +0.13 (+0.33%)
As of 08/21/2026 03:58 PM Eastern
Annual Income Statements for CareTrust REIT

Annual Income Statements for CareTrust REIT

This table shows CareTrust REIT's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
10 29 26 58 46 81 72 -7.51 54 125 321
Consolidated Net Income / (Loss)
10 29 26 58 46 81 72 -7.51 54 124 320
Net Income / (Loss) Continuing Operations
10 29 26 58 46 81 72 -7.51 54 124 320
Total Pre-Tax Income
10 29 26 58 46 81 72 -7.51 54 124 325
Total Operating Income
33 52 47 84 73 105 107 25 80 82 218
Total Gross Profit
74 102 130 154 161 176 192 182 199 229 381
Total Revenue
74 105 133 157 163 178 192 188 199 229 381
Operating Revenue
74 105 133 157 163 178 192 188 199 229 381
Total Cost of Revenue
0.00 2.55 2.73 2.96 2.90 1.87 0.00 5.04 0.00 0.00 0.00
Total Operating Expenses
41 50 84 70 88 72 86 158 119 148 163
Selling, General & Admin Expense
7.66 9.30 11 13 15 16 27 20 22 29 53
Depreciation Expense
24 32 39 46 52 53 55 50 51 57 93
Other Operating Expenses / (Income)
9.08 8.17 33 12 4.12 2.84 3.57 8.18 9.59 20 14
Impairment Charge
0.00 0.00 0.89 0.00 17 0.00 0.00 79 36 42 2.48
Total Other Income / (Expense), net
-23 -23 -21 -26 -26 -24 -35 -32 -26 43 107
Interest Expense
24 23 24 28 28 24 35 30 41 31 44
Interest & Investment Income
0.97 0.00 3.54 - - - - 8.63 19 67 95
Other Income / (Expense), net
0.00 -0.27 0.00 2.05 1.78 -0.04 -0.08 -11 -4.27 6.84 56
Income Tax Expense
- - - - - - - - 0.00 0.00 5.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - 0.00 0.00 -0.01 -0.68 -0.25
Basic Earnings per Share
$0.26 $0.52 $0.35 $0.73 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.81 $1.57
Weighted Average Basic Shares Outstanding
37.38M 56.03M 72.65M 79.39M 93.09M 95.20M 96.02M 96.70M 105.96M 154.80M 203.64M
Diluted Earnings per Share
$0.26 $0.52 $0.35 $0.72 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.80 $1.57
Weighted Average Diluted Shares Outstanding
37.38M 56.03M 72.65M 79.39M 93.10M 95.21M 96.09M 96.70M 106.15M 155.17M 204.09M
Weighted Average Basic & Diluted Shares Outstanding
48.15M 66.22M 76.14M 88.85M 95.47M 95.89M 97.05M 99.51M 130.50M 187.66M 223.40M
Cash Dividends to Common per Share
$0.64 $0.68 $0.74 $0.82 $0.90 $1.00 $1.06 $1.10 $1.12 $1.16 $1.34

Quarterly Income Statements for CareTrust REIT

This table shows CareTrust REIT's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
26 29 11 33 52 66 69 75 111 80 89
Consolidated Net Income / (Loss)
26 29 10 33 52 65 68 75 112 80 88
Net Income / (Loss) Continuing Operations
26 29 10 33 52 65 68 75 111 80 88
Total Pre-Tax Income
26 29 10 33 52 65 69 77 113 82 91
Total Operating Income
14 28 7.47 22 -20 45 52 61 59 71 77
Total Gross Profit
40 53 55 54 19 74 89 107 112 121 135
Total Revenue
41 54 55 57 20 74 89 107 110 121 135
Operating Revenue
41 54 55 57 20 74 89 107 110 121 135
Total Cost of Revenue
0.56 0.66 0.26 3.48 1.32 0.00 0.00 0.28 -1.32 0.00 0.00
Total Operating Expenses
26 25 48 31 38 30 37 45 52 50 57
Selling, General & Admin Expense
6.51 6.84 6.14 6.66 9.29 9.02 13 15 16 17 20
Depreciation Expense
13 13 14 14 16 18 21 27 27 29 30
Other Operating Expenses / (Income)
1.73 1.80 1.98 2.12 8.17 3.06 3.12 2.89 6.89 2.96 7.18
Total Other Income / (Expense), net
13 0.74 2.95 11 72 21 17 16 54 11 13
Interest Expense
8.27 8.23 8.68 8.94 5.12 6.67 13 13 11 11 15
Interest & Investment Income
- 9.57 13 20 - 22 24 25 24 22 27
Other Income / (Expense), net
1.63 -0.60 -1.86 -0.49 9.78 5.16 6.38 3.31 41 0.06 1.80
Income Tax Expense
- - 0.00 0.00 - 0.00 1.03 2.08 - 2.27 2.54
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.00 0.00 -0.34 -0.17 -0.18 -0.61 -0.64 0.03 0.97 -0.71 -0.76
Basic Earnings per Share
$0.24 $0.22 $0.07 $0.21 $0.31 $0.35 $0.36 $0.35 $0.51 $0.36 $0.38
Weighted Average Basic Shares Outstanding
105.96M 132.84M 144.90M 159.46M 154.80M 187.15M 192.44M 211.75M 203.64M 223.01M 233.75M
Diluted Earnings per Share
$0.24 $0.22 $0.07 $0.21 $0.30 $0.35 $0.35 $0.35 $0.52 $0.36 $0.38
Weighted Average Diluted Shares Outstanding
106.15M 133.20M 145.26M 159.85M 155.17M 187.42M 192.85M 212.27M 204.09M 223.96M 234.24M
Weighted Average Basic & Diluted Shares Outstanding
130.50M 142.06M 154.21M 171.45M 187.66M 191.69M 200.30M 223.30M 223.40M 236.24M 236.29M

Annual Cash Flow Statements for CareTrust REIT

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-14 -3.97 -0.59 30 -16 -1.41 0.98 -6.72 281 -81 -16
Net Cash From Operating Activities
40 64 89 99 126 146 157 144 155 244 394
Net Cash From Continuing Operating Activities
40 64 89 99 126 146 157 144 155 244 394
Net Income / (Loss) Continuing Operations
10 29 26 58 46 81 72 -7.51 54 124 320
Consolidated Net Income / (Loss)
10 29 26 58 46 81 72 -7.51 54 124 320
Depreciation Expense
24 32 39 46 52 53 55 50 51 57 93
Amortization Expense
2.20 2.24 2.10 1.94 2.00 1.95 2.05 2.10 2.05 -0.05 -2.47
Non-Cash Adjustments To Reconcile Net Income
1.79 1.25 26 -0.77 30 5.10 22 100 45 43 -43
Changes in Operating Assets and Liabilities, net
2.10 -0.39 -4.42 -5.51 -4.08 5.00 5.89 -0.32 2.39 20 26
Net Cash From Investing Activities
-235 -285 -303 -115 -316 -42 -193 -127 -268 -1,514 -1,461
Net Cash From Continuing Investing Activities
-235 -285 -303 -115 -316 -42 -193 -127 -268 -1,514 -1,461
Purchase of Property, Plant & Equipment
-233 -281 -0.40 -9.01 -6.29 -8.30 -6.01 -7.29 -11 -8.05 -15
Acquisitions
-1.75 -5.36 -297 -117 -321 -3.00 0.00 0.00 -5.58 -869 -174
Purchase of Investments
0.00 0.00 - - - -30 -1.25 -150 -60 -96 -97
Sale of Property, Plant & Equipment
- 2.86 0.00 13 3.50 6.61 6.96 45 16 14 79
Other Investing Activities, net
-0.19 -0.76 -13 -2.42 6.04 -8.72 -192 -16 -207 -555 -1,254
Net Cash From Financing Activities
181 216 213 46 173 -106 37 -24 394 1,189 1,051
Net Cash From Continuing Financing Activities
181 216 213 46 173 -106 37 -24 394 1,189 1,051
Repayment of Debt
-40 -301 -442 -135 -383 -75 -504 -120 -310 -284 -911
Payment of Dividends
-22 -37 -53 -63 -81 -93 -101 -106 -116 -172 -265
Issuance of Debt
80 355 538 65 443 65 620 160 185 75 1,150
Issuance of Common Equity
163 200 170 180 196 -0.40 23 47 636 1,573 1,080
Other Financing Activities, net
-0.15 -0.52 -0.87 -1.29 -2.52 -2.00 -1.33 -4.47 -1.48 -2.48 -3.33
Effect of Exchange Rate Changes
- - - - - - - - 0.00 0.00 0.52
Cash Interest Paid
22 21 30 26 26 22 23 26 40 28 40

Quarterly Cash Flow Statements for CareTrust REIT

This table details how cash moves in and out of CareTrust REIT's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
291 157 44 -118 -163 419 -326 406 -514 25 -174
Net Cash From Operating Activities
43 49 53 67 75 71 101 101 121 90 135
Net Cash From Continuing Operating Activities
43 49 53 67 75 71 101 101 121 90 135
Net Income / (Loss) Continuing Operations
26 29 10 33 52 65 68 75 112 80 88
Consolidated Net Income / (Loss)
26 29 10 33 52 65 68 75 112 80 88
Depreciation Expense
13 13 14 14 16 18 21 27 27 29 30
Amortization Expense
0.23 0.04 1.19 -1.34 0.06 0.04 0.06 -3.65 1.09 1.17 1.13
Non-Cash Adjustments To Reconcile Net Income
4.66 5.05 26 9.20 2.76 -3.15 -0.38 -4.53 -35 -2.48 -0.99
Changes in Operating Assets and Liabilities, net
-1.74 1.52 1.05 12 4.87 -8.56 12 7.42 15 -17 16
Net Cash From Investing Activities
-36 -123 -345 -359 -686 -36 -789 -76 -560 -105 -885
Net Cash From Continuing Investing Activities
-36 -123 -345 -359 -686 -36 -789 -76 -560 -105 -885
Purchase of Property, Plant & Equipment
-1.84 -0.40 -0.93 -2.87 -3.86 -2.28 -4.51 -3.23 -4.98 -3.16 -4.27
Acquisitions
-37 -4.11 -219 166 -0.39 -36 5.05 -5.36 -138 -0.15 -1.76
Purchase of Investments
-9.63 -52 -193 -260 -150 -6.39 -15 -27 -49 -31 -695
Other Investing Activities, net
11 -67 67 -267 -540 -36 -775 -40 -404 -71 -184
Net Cash From Financing Activities
284 231 336 174 447 383 362 381 -75 41 577
Net Cash From Continuing Financing Activities
284 231 336 174 447 383 362 381 -75 41 577
Repayment of Debt
-0.05 -0.02 - -275 -8.79 -0.14 -529 -382 - 0.00 -350
Payment of Dividends
-32 -37 -41 -45 -50 -55 -64 -69 -77 -77 -91
Issuance of Debt
- 0.00 75 - - 425 600 125 - 0.00 660
Issuance of Common Equity
316 270 303 494 506 17 355 707 1.44 128 357
Effect of Exchange Rate Changes
- - - - - 0.00 - 0.02 0.18 -0.48 -0.10
Cash Interest Paid
11 3.77 12 4.63 8.01 0.45 16 9.33 14 6.24 17

Annual Balance Sheets for CareTrust REIT

This table presents CareTrust REIT's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
673 925 1,185 1,292 1,519 1,504 1,641 1,621 2,085 3,437 5,148
Total Current Assets
16 15 13 57 34 31 30 25 318 347 531
Cash & Equivalents
11 7.50 6.91 37 20 19 20 13 294 214 198
Note & Lease Receivable
- - - - - - - - 0.00 96 92
Accounts Receivable
2.34 5.90 5.25 11 2.57 1.82 2.42 0.42 0.40 1.17 10
Prepaid Expenses
2.08 1.37 0.90 8.67 11 10 7.51 12 23 36 230
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,421 1,567 0.00 3,710
Total Noncurrent Assets
657 911 1,172 1,235 1,485 1,472 1,611 174 200 3,090 908
Long-Term Investments
8.48 14 18 18 33 15 15 156 180 795 899
Other Noncurrent Operating Assets
649 897 1,154 1,217 1,452 1,457 1,596 18 19 2,295 8.57
Total Liabilities & Shareholders' Equity
673 925 1,185 1,292 1,519 1,504 1,641 1,621 2,085 3,437 5,148
Total Liabilities
411 473 590 524 591 589 725 771 666 508 1,089
Total Current Liabilities
17 23 31 34 15 20 25 52 71 56 120
Accounts Payable
9.27 12 17 16 15 20 25 24 34 56 120
Total Noncurrent Liabilities
394 450 559 490 576 570 700 719 596 451 969
Long-Term Debt
394 450 559 490 555 546 673 719 596 397 894
Other Noncurrent Operating Liabilities
- - - - 22 24 26 - - 54 75
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - - 0.00 18 18
Total Equity & Noncontrolling Interests
262 452 595 768 928 914 916 849 1,419 2,911 4,041
Total Preferred & Common Equity
262 452 595 768 928 914 916 849 1,417 2,908 4,035
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
262 452 595 768 928 914 916 849 1,417 2,908 4,035
Common Stock
411 612 784 966 1,164 1,165 1,198 1,246 1,884 3,441 4,521
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - - - 0.00 5.87
Other Equity Adjustments
-148 -160 -189 -198 -236 -251 -282 -397 -468 -533 -492
Noncontrolling Interest
- - - - - - - 0.00 1.90 2.72 5.53

Quarterly Balance Sheets for CareTrust REIT

This table presents CareTrust REIT's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
1,622 1,737 1,768 2,348 2,699 2,921 3,884 4,657 5,089 5,237 5,929
Total Current Assets
58 16 25 479 527 412 199 494 908 421 709
Cash & Equivalents
28 1.15 3.49 451 495 377 27 306 712 223 48
Note & Lease Receivable
- - - - - - 97 97 98 93 556
Accounts Receivable
0.44 0.39 0.38 0.40 1.10 0.88 1.95 2.69 7.39 14 18
Prepaid Expenses
30 14 21 28 31 34 74 88 90 91 87
Plant, Property, & Equipment, net
0.00 1,528 1,536 1,619 1,706 1,749 2,252 0.00 3,272 3,877 4,063
Total Noncurrent Assets
1,564 193 207 250 466 760 1,433 4,162 909 939 1,157
Long-Term Investments
141 167 181 233 434 741 800 841 871 932 1,148
Other Noncurrent Operating Assets
1,423 26 26 16 32 19 633 3,321 37 7.87 8.86
Total Liabilities & Shareholders' Equity
1,622 1,737 1,768 2,348 2,699 2,921 3,884 4,657 5,089 5,237 5,929
Total Liabilities
782 924 657 672 753 496 936 1,332 1,072 1,083 1,416
Total Current Liabilities
24 329 61 76 82 99 114 109 178 100 119
Accounts Payable
24 21 29 35 37 50 51 109 103 100 119
Total Noncurrent Liabilities
758 595 595 596 671 397 822 1,222 894 983 1,297
Long-Term Debt
730 595 595 596 671 397 822 996 894 895 1,205
Other Noncurrent Operating Liabilities
28 - - - - - - 226 - 89 92
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - 17 21 18 16 13
Total Equity & Noncontrolling Interests
840 813 1,111 1,676 1,946 2,425 2,931 3,304 3,999 4,138 4,500
Total Preferred & Common Equity
840 813 1,110 1,674 1,944 2,422 2,927 3,301 3,994 4,132 4,491
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
840 813 1,110 1,674 1,944 2,422 2,927 3,301 3,994 4,132 4,491
Common Stock
1,246 1,247 1,567 2,154 2,458 2,953 3,457 3,810 4,519 4,641 4,999
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - 19 3.71 -8.97 -4.00
Other Equity Adjustments
-405 -434 -457 -480 -514 -530 -530 -528 -528 -500 -503
Noncontrolling Interest
- - 1.06 2.30 2.08 2.54 3.47 3.51 4.57 6.57 8.54

Annual Metrics And Ratios for CareTrust REIT

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.62% 41.48% 27.04% 18.02% 4.12% 9.14% 7.86% -2.52% 5.92% 15.44% 66.14%
EBITDA Growth
261.18% 45.41% 1.58% 52.04% -3.86% 24.11% 2.91% -59.53% 94.04% 12.81% 150.96%
EBIT Growth
506.69% 57.70% -10.90% 84.35% -13.17% 40.34% 1.87% -86.97% 443.63% 17.12% 210.02%
NOPAT Growth
680.99% 58.50% -11.35% 79.95% -13.17% 43.82% 1.91% -83.74% 360.09% 2.27% 163.52%
Net Income Growth
223.22% 192.54% -11.85% 123.87% -19.96% 74.44% -10.99% -110.43% 815.72% 131.56% 157.47%
EPS Growth
172.22% 100.00% -32.69% 105.71% -31.94% 73.47% -12.94% -110.81% 725.00% 60.00% 96.25%
Operating Cash Flow Growth
83.76% 60.06% 37.82% 11.89% 27.11% 15.39% 7.64% -7.94% 7.17% 57.82% 61.32%
Free Cash Flow Firm Growth
-780.70% -11.34% -4.57% 102.69% -2,558.06% 179.55% -120.24% 765.38% -148.05% -928.21% -100.65%
Invested Capital Growth
47.92% 38.50% 28.13% 6.85% 17.01% -0.19% 9.00% -8.19% 10.45% 50.48% 66.40%
Revenue Q/Q Growth
8.17% 7.07% 6.55% 37.23% -17.68% -0.05% 3.28% -3.63% -5.36% -14.79% 14.13%
EBITDA Q/Q Growth
96.38% -6.66% -10.23% 66.77% -19.99% -0.46% -0.83% -14.45% -5.59% -22.57% 27.85%
EBIT Q/Q Growth
490.43% -12.81% -21.05% 161.01% -31.09% -0.90% -2.01% -39.59% -10.23% -33.50% 32.22%
NOPAT Q/Q Growth
490.43% -12.37% -21.05% 171.72% -32.60% 0.57% -2.09% -16.57% -15.21% -39.24% 17.69%
Net Income Q/Q Growth
77.19% 13.04% -19.17% 29.77% 12.42% 0.49% -3.74% -107.06% 28.50% 25.99% 23.20%
EPS Q/Q Growth
36.84% 8.33% -27.08% 28.57% 6.52% 1.19% -3.90% -100.00% 21.95% 8.11% 16.30%
Operating Cash Flow Q/Q Growth
19.84% 6.09% 8.49% 5.41% 3.41% 4.45% 0.74% -3.19% 6.12% 15.37% 13.14%
Free Cash Flow Firm Q/Q Growth
0.00% -112.25% 9.15% 107.98% -5.84% -20.52% 61.73% 13.42% -684.70% -996.65% 9.71%
Invested Capital Q/Q Growth
-1.33% 10.84% 4.98% 2.77% 0.37% 2.41% -0.24% -1.68% 1.41% 35.27% 13.34%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 97.56% 97.94% 98.11% 98.23% 98.95% 100.00% 97.31% 98.28% 97.51% 100.00%
EBITDA Margin
80.35% 82.58% 66.03% 85.07% 78.55% 89.33% 85.23% 35.39% 64.83% 63.35% 95.69%
Operating Margin
44.76% 50.14% 34.99% 53.35% 44.50% 58.64% 55.40% 13.20% 40.13% 35.55% 57.27%
EBIT Margin
44.76% 49.89% 34.99% 54.66% 45.58% 58.61% 55.36% 7.40% 37.98% 38.54% 71.91%
Profit (Net Income) Margin
13.56% 28.04% 19.46% 36.91% 28.37% 45.35% 37.42% -4.00% 27.05% 54.26% 84.08%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.46%
Interest Burden Percent
30.30% 56.20% 55.60% 67.52% 62.24% 77.36% 67.60% -54.09% 71.22% 140.80% 118.76%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.54%
Return on Invested Capital (ROIC)
6.14% 6.84% 4.57% 7.08% 5.49% 7.33% 7.15% 1.16% 5.31% 4.13% 6.96%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.43% 1.20% 0.39% 1.93% -0.04% 2.65% 1.14% -2.92% -1.76% -17.29% -18.92%
Return on Net Nonoperating Assets (RNNOA)
-0.80% 1.38% 0.37% 1.42% -0.02% 1.46% 0.72% -2.01% -0.57% 1.59% 2.21%
Return on Equity (ROE)
5.34% 8.21% 4.94% 8.50% 5.47% 8.78% 7.87% -0.85% 4.74% 5.72% 9.17%
Cash Return on Invested Capital (CROIC)
-32.52% -25.45% -20.09% 0.46% -10.18% 7.52% -1.46% 9.70% -4.63% -36.18% -42.89%
Operating Return on Assets (OROA)
5.77% 6.53% 4.41% 6.93% 5.30% 6.92% 6.77% 0.85% 4.07% 3.20% 6.38%
Return on Assets (ROA)
1.75% 3.67% 2.45% 4.68% 3.30% 5.35% 4.58% -0.46% 2.90% 4.51% 7.46%
Return on Common Equity (ROCE)
5.34% 8.21% 4.94% 8.50% 5.47% 8.78% 7.87% -0.85% 4.73% 5.69% 9.11%
Return on Equity Simple (ROE_SIMPLE)
3.83% 6.49% 4.35% 7.54% 5.00% 8.85% 7.86% -0.88% 3.79% 4.28% 0.00%
Net Operating Profit after Tax (NOPAT)
33 52 47 84 73 105 107 17 80 82 215
NOPAT Margin
44.76% 50.14% 34.99% 53.35% 44.50% 58.64% 55.40% 9.24% 40.13% 35.55% 56.39%
Net Nonoperating Expense Percent (NNEP)
6.56% 5.64% 4.18% 5.16% 5.53% 4.68% 6.01% 4.08% 7.07% 21.42% 25.88%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 1.10% 3.96% 2.46% 4.35%
Cost of Revenue to Revenue
0.00% 2.44% 2.06% 1.89% 1.77% 1.05% 0.00% 2.69% 1.72% 2.49% 0.00%
SG&A Expenses to Revenue
10.35% 8.88% 8.36% 8.00% 9.28% 9.14% 13.97% 10.75% 10.98% 12.62% 14.02%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
55.24% 47.42% 62.95% 44.76% 53.73% 40.32% 44.60% 84.11% 58.14% 61.95% 42.73%
Earnings before Interest and Taxes (EBIT)
33 52 47 86 74 105 106 14 75 88 274
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
59 86 88 134 128 159 164 66 129 145 364
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.32 1.35 1.54 1.52 1.67 1.93 2.11 1.92 1.80 1.59 2.00
Price to Tangible Book Value (P/TBV)
1.32 1.35 1.54 1.52 1.67 1.93 2.11 1.92 1.80 1.59 2.00
Price to Revenue (P/Rev)
4.67 5.85 6.87 7.45 9.48 9.89 10.03 8.70 12.84 20.23 21.20
Price to Earnings (P/E)
34.40 20.85 35.29 20.19 33.42 21.82 26.81 0.00 47.47 37.08 25.19
Dividend Yield
8.93% 6.45% 6.15% 5.88% 5.55% 5.43% 5.33% 6.54% 5.23% 4.29% 3.71%
Earnings Yield
2.91% 4.80% 2.83% 4.95% 2.99% 4.58% 3.73% 0.00% 2.11% 2.70% 3.97%
Enterprise Value to Invested Capital (EV/IC)
1.12 1.17 1.27 1.31 1.44 1.60 1.65 1.53 1.70 1.71 2.05
Enterprise Value to Revenue (EV/Rev)
9.72 9.94 10.88 10.22 12.55 12.76 13.35 11.64 13.46 17.65 20.73
Enterprise Value to EBITDA (EV/EBITDA)
12.10 12.04 16.48 12.02 15.97 14.29 15.66 32.89 20.77 27.86 21.66
Enterprise Value to EBIT (EV/EBIT)
21.72 19.92 31.10 18.70 27.52 21.77 24.12 157.26 35.44 45.80 28.82
Enterprise Value to NOPAT (EV/NOPAT)
21.72 19.82 31.10 19.16 28.20 21.77 24.10 125.97 33.54 49.64 36.75
Enterprise Value to Operating Cash Flow (EV/OCF)
17.87 16.15 16.30 16.15 16.23 15.62 16.37 15.11 17.27 16.57 20.04
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 292.25 0.00 21.20 0.00 15.10 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.50 0.99 0.94 0.64 0.60 0.60 0.74 0.85 0.42 0.14 0.22
Long-Term Debt to Equity
1.50 0.99 0.94 0.64 0.60 0.60 0.74 0.85 0.42 0.14 0.22
Financial Leverage
1.87 1.15 0.94 0.73 0.56 0.55 0.63 0.69 0.32 -0.09 -0.12
Leverage Ratio
3.06 2.24 2.02 1.82 1.66 1.64 1.72 1.85 1.63 1.27 1.23
Compound Leverage Factor
0.93 1.26 1.12 1.23 1.03 1.27 1.16 -1.00 1.16 1.79 1.46
Debt to Total Capital
60.03% 49.85% 48.45% 38.93% 37.42% 37.38% 42.37% 45.86% 29.57% 11.93% 18.05%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
60.03% 49.85% 48.45% 38.93% 37.42% 37.38% 42.37% 45.86% 29.57% 11.93% 18.05%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.09% 0.63% 0.48%
Common Equity to Total Capital
39.97% 50.15% 51.55% 61.07% 62.58% 62.62% 57.63% 54.14% 70.34% 87.44% 81.47%
Debt to EBITDA
6.63 5.20 6.37 3.67 4.32 3.43 4.11 10.84 4.63 2.73 2.45
Net Debt to EBITDA
6.29 4.96 6.08 3.26 3.90 3.21 3.89 8.29 0.94 -4.21 -0.56
Long-Term Debt to EBITDA
6.63 5.20 6.37 3.67 4.32 3.43 4.11 10.84 4.63 2.73 2.45
Debt to NOPAT
11.89 8.57 12.01 5.85 7.63 5.22 6.32 41.53 7.47 4.87 4.16
Net Debt to NOPAT
11.29 8.16 11.48 5.19 6.89 4.89 5.99 31.75 1.52 -7.51 -0.95
Long-Term Debt to NOPAT
11.89 8.57 12.01 5.85 7.63 5.22 6.32 41.53 7.47 4.87 4.16
Altman Z-Score
0.77 1.06 1.15 1.70 1.86 2.15 1.93 1.39 2.65 5.72 4.79
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.08% 0.53% 0.64%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.94 0.64 0.42 1.68 2.26 1.59 1.17 0.49 4.51 3.13 4.41
Quick Ratio
0.81 0.58 0.39 1.43 1.53 1.06 0.88 0.26 4.18 2.81 2.50
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-176 -195 -204 5.49 -135 107 -22 145 -69 -714 -1,324
Operating Cash Flow to CapEx
17.30% 23.13% 22,034.74% 0.00% 4,526.70% 8,628.48% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-7.30 -8.54 -8.44 0.20 -4.80 4.54 -0.63 4.82 -1.70 -23.06 -30.02
Operating Cash Flow to Interest Expense
1.67 2.82 3.67 3.57 4.49 6.16 4.55 4.81 3.79 7.89 8.94
Operating Cash Flow Less CapEx to Interest Expense
-8.00 -9.36 3.65 3.71 4.39 6.09 4.57 6.07 3.92 8.08 10.39
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.13 0.13 0.13 0.13 0.12 0.12 0.12 0.12 0.11 0.08 0.09
Accounts Receivable Turnover
31.94 25.41 23.85 18.86 23.41 81.17 90.71 132.33 489.76 292.25 66.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.12 0.00
Accounts Payable Turnover
0.00 0.24 0.19 0.18 0.19 0.11 0.00 0.20 0.12 0.13 0.00
Days Sales Outstanding (DSO)
11.43 14.36 15.30 19.35 15.59 4.50 4.02 2.76 0.75 1.25 5.53
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 1,532.60 1,973.24 2,055.28 1,947.74 3,372.10 0.00 1,802.47 3,111.08 2,884.42 0.00
Cash Conversion Cycle (CCC)
11.43 -1,518.24 -1,957.94 -2,035.93 -1,932.15 -3,367.60 4.02 -1,799.71 -3,110.34 -2,883.17 5.53
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
644 892 1,143 1,221 1,429 1,426 1,554 1,427 1,576 2,372 3,856
Invested Capital Turnover
0.14 0.14 0.13 0.13 0.12 0.13 0.13 0.13 0.13 0.12 0.12
Increase / (Decrease) in Invested Capital
209 248 251 78 208 -2.77 128 -127 149 796 1,539
Enterprise Value (EV)
719 1,040 1,447 1,604 2,050 2,276 2,568 2,182 2,674 4,047 7,895
Market Capitalization
345 612 913 1,169 1,549 1,764 1,930 1,632 2,551 4,638 8,075
Book Value per Share
$5.45 $7.79 $7.83 $9.16 $9.71 $9.55 $9.44 $8.75 $11.89 $16.96 $18.07
Tangible Book Value per Share
$5.45 $7.79 $7.83 $9.16 $9.71 $9.55 $9.44 $8.75 $11.89 $16.96 $18.07
Total Capital
656 902 1,154 1,258 1,482 1,460 1,589 1,569 2,014 3,326 4,953
Total Debt
394 450 559 490 555 546 673 719 596 397 894
Total Long-Term Debt
394 450 559 490 555 546 673 719 596 397 894
Net Debt
374 428 534 435 501 512 638 550 121 -612 -203
Capital Expenditures (CapEx)
233 279 0.40 -3.99 2.79 1.69 -0.95 -38 -5.34 -5.89 -64
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-13 -16 -25 -14 -1.54 -7.30 -15 -40 -47 22 213
Debt-free Net Working Capital (DFNWC)
-1.08 -8.45 -18 23 19 12 4.42 -27 248 236 411
Net Working Capital (NWC)
-1.08 -8.45 -18 23 19 12 4.42 -27 248 236 411
Net Nonoperating Expense (NNE)
23 23 21 26 26 24 35 25 26 -43 -105
Net Nonoperating Obligations (NNO)
382 439 548 453 501 512 638 578 157 -558 -203
Total Depreciation and Amortization (D&A)
26 34 41 48 54 55 57 52 53 57 91
Debt-free, Cash-free Net Working Capital to Revenue
-16.96% -15.23% -19.03% -8.73% -0.94% -4.09% -8.05% -21.23% -23.56% 9.63% 55.80%
Debt-free Net Working Capital to Revenue
-1.46% -8.07% -13.84% 14.72% 11.50% 6.52% 2.30% -14.20% 124.70% 102.89% 107.79%
Net Working Capital to Revenue
-1.46% -8.07% -13.84% 14.72% 11.50% 6.52% 2.30% -14.20% 124.70% 102.89% 107.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.26 $0.52 $0.35 $0.73 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.81 $1.57
Adjusted Weighted Average Basic Shares Outstanding
37.38M 56.03M 72.65M 79.39M 93.09M 95.20M 96.02M 96.70M 105.96M 154.80M 203.64M
Adjusted Diluted Earnings per Share
$0.26 $0.52 $0.35 $0.72 $0.49 $0.85 $0.74 ($0.08) $0.50 $0.80 $1.57
Adjusted Weighted Average Diluted Shares Outstanding
37.38M 56.03M 72.65M 79.39M 93.10M 95.21M 96.09M 96.70M 106.15M 155.17M 204.09M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
48.15M 66.22M 76.14M 88.85M 95.47M 95.89M 97.05M 99.51M 130.50M 187.66M 223.40M
Normalized Net Operating Profit after Tax (NOPAT)
23 37 33 59 63 73 75 73 81 87 217
Normalized NOPAT Margin
31.33% 35.24% 24.96% 37.35% 38.30% 41.04% 38.78% 38.75% 40.89% 37.78% 57.03%
Pre Tax Income Margin
13.56% 28.04% 19.46% 36.91% 28.37% 45.35% 37.42% -4.00% 27.05% 54.26% 85.40%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.38 2.28 1.92 3.08 2.65 4.42 3.09 0.46 1.85 2.85 6.21
NOPAT to Interest Expense
1.38 2.29 1.92 3.01 2.59 4.42 3.09 0.58 1.95 2.63 4.87
EBIT Less CapEx to Interest Expense
-8.30 -9.89 1.91 3.22 2.55 4.35 3.11 1.72 1.98 3.04 7.67
NOPAT Less CapEx to Interest Expense
-8.30 -9.88 1.91 3.15 2.49 4.35 3.12 1.84 2.08 2.82 6.33
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
217.16% 126.97% 203.24% 108.76% 173.90% 115.20% 140.01% -1,414.04% 215.06% 138.45% 82.76%
Augmented Payout Ratio
217.16% 126.97% 203.24% 108.76% 173.90% 115.20% 140.01% -1,414.04% 215.06% 138.45% 82.76%

Quarterly Metrics And Ratios for CareTrust REIT

This table displays calculated financial ratios and metrics derived from CareTrust REIT's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 223,404,715.00 236,240,235.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 223,404,715.00 236,240,235.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.36 0.38
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-6.07% 5.72% 33.63% 38.48% -50.87% 39.16% 60.48% 87.52% 74.61% 62.28% 51.31%
EBITDA Growth
3.60% -2.40% 42.98% 61.06% -80.30% 67.40% 308.57% 145.14% 162.17% 50.46% 38.99%
EBIT Growth
0.18% -5.66% 80.91% 106.58% -164.59% 84.54% 941.88% 194.50% 200.20% 43.00% 35.73%
NOPAT Growth
-29.18% -5.30% 180.30% 66.24% -243.33% 62.15% 587.13% 166.05% 151.26% 55.01% 46.95%
Net Income Growth
82.85% 49.53% 2,252.48% 283.14% 97.59% 126.76% 551.78% 125.18% 116.07% 21.95% 29.95%
EPS Growth
60.00% 15.79% 800.00% 162.50% 25.00% 59.09% 400.00% 66.67% 73.33% 2.86% 8.57%
Operating Cash Flow Growth
26.46% 39.01% 66.24% 49.08% 76.25% 46.21% 90.23% 50.06% 60.83% 26.59% 33.71%
Free Cash Flow Firm Growth
-192.32% -227.20% -649.80% -102.93% -502.20% -568.60% -682.90% -798.67% -106.13% 38.70% 8.47%
Invested Capital Growth
10.45% 16.23% 11.95% 12.82% 50.48% 84.64% 83.18% 94.03% 66.40% 29.49% 42.46%
Revenue Q/Q Growth
-27.41% 31.90% 9.23% 12.32% -74.25% 273.61% 19.43% 20.53% 2.98% 9.48% 11.35%
EBITDA Q/Q Growth
-15.40% 41.85% -32.32% 60.72% -89.65% 1,105.28% 16.52% 10.07% 46.14% -20.77% 8.97%
EBIT Q/Q Growth
-24.69% 78.11% -48.36% 121.05% -123.54% 608.92% 15.62% 10.72% 54.59% -29.00% 11.58%
NOPAT Q/Q Growth
-46.44% 103.60% -44.24% 103.79% -146.18% 330.33% 13.00% 16.49% -0.98% 16.60% 9.13%
Net Income Q/Q Growth
202.75% 9.34% -63.76% 219.41% 56.13% 25.48% 4.16% 10.35% 49.82% -29.18% 10.98%
EPS Q/Q Growth
200.00% -8.33% -68.18% 200.00% 42.86% 16.67% 0.00% 0.00% 48.57% -30.77% 5.56%
Operating Cash Flow Q/Q Growth
-5.41% 14.41% 8.51% 26.94% 11.84% -5.09% 41.18% 0.14% 19.87% -25.29% 49.12%
Free Cash Flow Firm Q/Q Growth
-75.48% -47.25% 13.56% 4.57% -420.73% -63.49% -4.28% -14.30% 6.89% 44.73% -55.63%
Invested Capital Q/Q Growth
1.41% 3.34% 6.41% 1.17% 35.27% 26.79% 5.57% 7.17% 13.34% 0.98% 16.14%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
98.61% 98.77% 99.63% 95.51% 93.37% 99.86% 98.95% 99.74% 101.20% 100.00% 100.00%
EBITDA Margin
71.10% 76.47% 49.59% 70.96% 28.51% 91.98% 89.74% 81.96% 116.31% 84.17% 82.37%
Operating Margin
33.92% 52.36% 30.41% 55.18% -98.95% 61.00% 58.59% 57.33% 53.64% 58.76% 57.60%
EBIT Margin
37.94% 51.23% 27.72% 54.55% -49.87% 67.94% 65.77% 60.41% 90.69% 58.81% 58.93%
Profit (Net Income) Margin
64.82% 53.74% 15.12% 43.00% 260.71% 87.56% 76.36% 69.92% 101.72% 65.80% 65.58%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 98.66% 98.51% 97.30% 99.11% 97.22% 97.21%
Interest Burden Percent
170.86% 104.89% 54.55% 78.83% -522.74% 130.64% 117.87% 118.93% 113.16% 115.08% 114.48%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.49% 2.70% 0.00% 2.78% 2.79%
Return on Invested Capital (ROIC)
4.49% 6.96% 4.59% 8.98% -11.49% 6.59% 6.67% 7.22% 6.62% 7.07% 6.88%
ROIC Less NNEP Spread (ROIC-NNEP)
7.90% 7.25% 0.55% 17.23% -47.30% 352.32% -2.45% 4.87% -6.40% -3.34% -11.36%
Return on Net Nonoperating Assets (RNNOA)
2.56% 1.48% 0.11% -1.11% 4.36% 0.87% 0.17% -0.97% 0.75% 0.09% 0.21%
Return on Equity (ROE)
7.05% 8.44% 4.70% 7.87% -7.14% 7.46% 6.84% 6.25% 7.37% 7.17% 7.09%
Cash Return on Invested Capital (CROIC)
-4.63% -9.85% -4.14% -3.94% -36.18% -55.20% -52.90% -56.88% -42.89% -18.76% -28.18%
Operating Return on Assets (OROA)
4.07% 5.20% 3.09% 6.26% -4.14% 5.45% 5.07% 5.03% 8.05% 5.51% 5.27%
Return on Assets (ROA)
6.95% 5.45% 1.69% 4.94% 21.65% 7.03% 5.89% 5.83% 9.03% 6.16% 5.86%
Return on Common Equity (ROCE)
7.04% 8.44% 4.69% 7.86% -7.10% 7.42% 6.81% 6.23% 7.32% 7.13% 7.04%
Return on Equity Simple (ROE_SIMPLE)
0.00% 3.78% 3.81% 4.08% 0.00% 5.49% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
14 28 21 43 -20 45 51 60 59 69 75
NOPAT Margin
33.92% 52.36% 30.41% 55.18% -98.95% 61.00% 57.72% 55.78% 53.64% 57.13% 55.99%
Net Nonoperating Expense Percent (NNEP)
-3.41% -0.29% 4.04% -8.25% 35.80% -345.73% 9.13% 2.35% 13.02% 10.42% 18.24%
Return On Investment Capital (ROIC_SIMPLE)
0.68% 1.23% - - -0.60% 1.21% 1.19% 1.22% 1.20% 1.37% 1.32%
Cost of Revenue to Revenue
1.39% 1.23% 0.37% 4.49% 6.63% 0.14% 1.05% 0.26% -1.20% 0.00% 0.00%
SG&A Expenses to Revenue
16.04% 12.78% 8.91% 8.61% 46.60% 12.12% 14.11% 14.39% 14.88% 14.44% 14.50%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
64.69% 46.41% 69.22% 40.33% 192.32% 38.86% 40.35% 42.41% 47.56% 41.24% 42.40%
Earnings before Interest and Taxes (EBIT)
15 27 19 42 -9.94 51 58 65 100 71 79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
29 41 34 55 5.68 68 80 88 128 102 111
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.80 1.66 1.83 1.96 1.59 1.83 1.78 1.74 2.00 1.98 2.12
Price to Tangible Book Value (P/TBV)
1.80 1.66 1.83 1.96 1.59 1.83 1.78 1.74 2.00 1.98 2.12
Price to Revenue (P/Rev)
12.84 13.79 14.40 17.69 20.23 21.43 20.67 20.81 21.20 19.16 20.16
Price to Earnings (P/E)
47.47 43.93 47.87 47.95 37.08 33.08 26.67 26.58 25.19 24.45 26.82
Dividend Yield
5.23% 4.84% 4.54% 3.73% 4.29% 4.22% 4.09% 3.73% 3.71% 3.81% 3.59%
Earnings Yield
2.11% 2.28% 2.09% 2.09% 2.70% 3.02% 3.75% 3.76% 3.97% 4.09% 3.73%
Enterprise Value to Invested Capital (EV/IC)
1.70 1.65 1.91 2.30 1.71 1.79 1.81 1.85 2.05 2.04 2.11
Enterprise Value to Revenue (EV/Rev)
13.46 13.36 13.37 15.02 17.65 21.50 20.23 18.81 20.73 18.61 20.22
Enterprise Value to EBITDA (EV/EBITDA)
20.77 21.08 19.85 21.54 27.86 31.13 24.63 22.03 21.66 19.95 22.26
Enterprise Value to EBIT (EV/EBIT)
35.44 36.49 29.80 30.41 45.80 48.24 34.91 30.31 28.82 26.92 30.25
Enterprise Value to NOPAT (EV/NOPAT)
33.54 34.46 28.26 30.12 49.64 54.39 39.98 34.40 36.75 33.20 36.28
Enterprise Value to Operating Cash Flow (EV/OCF)
17.27 15.98 17.46 19.08 16.57 20.16 18.24 18.03 20.04 19.25 21.39
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.42 0.36 0.34 0.16 0.14 0.28 0.30 0.22 0.22 0.22 0.27
Long-Term Debt to Equity
0.42 0.36 0.34 0.16 0.14 0.28 0.30 0.22 0.22 0.22 0.27
Financial Leverage
0.32 0.20 0.19 -0.06 -0.09 0.00 -0.07 -0.20 -0.12 -0.03 -0.02
Leverage Ratio
1.63 1.58 1.61 1.33 1.27 1.35 1.40 1.24 1.23 1.28 1.35
Compound Leverage Factor
2.79 1.66 0.88 1.05 -6.64 1.76 1.64 1.48 1.39 1.48 1.55
Debt to Total Capital
29.57% 26.23% 25.65% 14.06% 11.93% 21.81% 23.06% 18.20% 18.05% 17.72% 21.07%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
29.57% 26.23% 25.65% 14.06% 11.93% 21.81% 23.06% 18.20% 18.05% 17.72% 21.07%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.09% 0.10% 0.08% 0.09% 0.63% 0.55% 0.57% 0.47% 0.48% 0.44% 0.38%
Common Equity to Total Capital
70.34% 73.67% 74.27% 85.85% 87.44% 77.64% 76.38% 81.33% 81.47% 81.84% 78.54%
Debt to EBITDA
4.63 4.66 4.02 2.12 2.73 4.76 4.28 3.14 2.45 2.24 2.80
Net Debt to EBITDA
0.94 -0.69 -1.54 -3.84 -4.21 -0.02 -0.65 -2.42 -0.56 -0.65 0.02
Long-Term Debt to EBITDA
4.63 4.66 4.02 2.12 2.73 4.76 4.28 3.14 2.45 2.24 2.80
Debt to NOPAT
7.47 7.63 5.73 2.96 4.87 8.31 6.94 4.90 4.16 3.74 4.57
Net Debt to NOPAT
1.52 -1.13 -2.20 -5.38 -7.51 -0.04 -1.05 -3.78 -0.95 -1.09 0.03
Long-Term Debt to NOPAT
7.47 7.63 5.73 2.96 4.87 8.31 6.94 4.90 4.16 3.74 4.57
Altman Z-Score
2.56 2.81 3.15 6.02 5.62 3.57 2.84 4.17 4.68 4.74 4.28
Noncontrolling Interest Sharing Ratio
0.08% 0.09% 0.08% 0.10% 0.53% 0.50% 0.50% 0.40% 0.64% 0.61% 0.59%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.51 6.27 6.44 4.14 3.13 1.74 4.53 5.10 4.41 4.21 5.98
Quick Ratio
4.18 5.91 6.06 3.80 2.81 1.10 3.72 4.60 2.50 3.30 5.24
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-135 -199 -164 -157 -815 -1,333 -1,390 -1,589 -1,479 -818 -1,273
Operating Cash Flow to CapEx
0.00% 13,869.32% 6,374.85% 0.00% 0.00% 0.00% 2,235.97% 3,124.21% 0.00% 2,859.65% 3,157.93%
Free Cash Flow to Firm to Interest Expense
-16.38 -24.23 -18.91 -17.52 -159.19 -199.88 -106.62 -122.11 -130.02 -72.73 -83.04
Operating Cash Flow to Interest Expense
5.16 5.93 6.10 7.52 14.68 10.70 7.73 7.76 10.63 8.04 8.79
Operating Cash Flow Less CapEx to Interest Expense
5.16 5.89 6.01 7.75 15.66 17.02 7.38 7.51 13.26 7.76 8.51
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.11 0.10 0.11 0.11 0.08 0.08 0.08 0.08 0.09 0.09 0.09
Accounts Receivable Turnover
489.76 478.04 333.88 425.75 292.25 212.41 150.00 80.71 66.00 52.05 45.80
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.13 0.00 0.15 0.16 0.12 0.13 0.00 0.13 0.00 0.14 0.00
Accounts Payable Turnover
0.12 0.11 0.09 0.13 0.13 0.12 0.08 0.03 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.75 0.76 1.09 0.86 1.25 1.72 2.43 4.52 5.53 7.01 7.97
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
3,111.08 3,476.86 3,905.98 2,893.89 2,884.42 3,054.43 4,566.72 10,548.69 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
-3,110.34 -3,476.10 -3,904.89 -2,893.03 -2,883.17 -3,052.71 -4,564.28 -10,544.17 5.53 7.01 7.97
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,576 1,629 1,733 1,753 2,372 3,007 3,174 3,402 3,856 3,894 4,522
Invested Capital Turnover
0.13 0.13 0.15 0.16 0.12 0.11 0.12 0.13 0.12 0.12 0.12
Increase / (Decrease) in Invested Capital
149 227 185 199 796 1,378 1,441 1,649 1,539 887 1,348
Enterprise Value (EV)
2,674 2,692 3,310 4,040 4,047 5,380 5,740 6,279 7,895 7,950 9,563
Market Capitalization
2,551 2,779 3,566 4,759 4,638 5,363 5,866 6,946 8,075 8,188 9,532
Book Value per Share
$11.89 $12.60 $13.68 $15.71 $16.96 $15.60 $17.22 $19.94 $18.07 $18.49 $19.01
Tangible Book Value per Share
$11.89 $12.60 $13.68 $15.71 $16.96 $15.60 $17.22 $19.94 $18.07 $18.49 $19.01
Total Capital
2,014 2,272 2,617 2,821 3,326 3,770 4,321 4,911 4,953 5,049 5,718
Total Debt
596 596 671 397 397 822 996 894 894 895 1,205
Total Long-Term Debt
596 596 671 397 397 822 996 894 894 895 1,205
Net Debt
121 -89 -258 -721 -612 -4.16 -151 -690 -203 -260 9.00
Capital Expenditures (CapEx)
-0.01 0.35 0.83 -2.06 -5.01 -42 4.51 3.23 -30 3.16 4.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-47 -48 -50 -65 22 58 79 18 213 98 543
Debt-free Net Working Capital (DFNWC)
248 403 445 312 236 85 385 730 411 321 590
Net Working Capital (NWC)
248 403 445 312 236 85 385 730 411 321 590
Net Nonoperating Expense (NNE)
-13 -0.74 11 9.42 -72 -20 -17 -15 -53 -10 -13
Net Nonoperating Obligations (NNO)
157 -47 -213 -671 -558 59 -151 -615 -203 -260 9.00
Total Depreciation and Amortization (D&A)
13 14 15 13 16 18 21 23 28 31 32
Debt-free, Cash-free Net Working Capital to Revenue
-23.56% -23.98% -20.29% -24.06% 9.63% 23.32% 27.97% 5.35% 55.80% 22.89% 114.78%
Debt-free Net Working Capital to Revenue
124.70% 199.93% 179.70% 116.09% 102.89% 33.91% 135.84% 218.82% 107.79% 75.13% 124.84%
Net Working Capital to Revenue
124.70% 199.93% 179.70% 116.09% 102.89% 33.91% 135.84% 218.82% 107.79% 75.13% 124.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.24 $0.22 $0.07 $0.21 $0.31 $0.35 $0.36 $0.35 $0.51 $0.36 $0.38
Adjusted Weighted Average Basic Shares Outstanding
105.96M 132.84M 144.90M 159.46M 154.80M 187.15M 192.44M 211.75M 203.64M 223.01M 233.75M
Adjusted Diluted Earnings per Share
$0.24 $0.22 $0.07 $0.21 $0.30 $0.35 $0.35 $0.35 $0.52 $0.36 $0.38
Adjusted Weighted Average Diluted Shares Outstanding
106.15M 133.20M 145.26M 159.85M 155.17M 187.42M 192.85M 212.27M 204.09M 223.96M 234.24M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
130.50M 142.06M 154.21M 171.45M 187.66M 191.69M 200.30M 223.30M 223.40M 236.24M 236.29M
Normalized Net Operating Profit after Tax (NOPAT)
13 22 33 36 -10 32 51 60 43 69 75
Normalized NOPAT Margin
32.01% 40.24% 47.42% 46.24% -50.46% 42.70% 57.72% 56.19% 38.84% 57.13% 55.99%
Pre Tax Income Margin
64.82% 53.74% 15.12% 43.00% 260.71% 88.76% 77.52% 71.85% 102.63% 67.68% 67.47%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.86 3.33 2.20 4.72 -1.94 7.58 4.49 4.98 8.80 6.32 5.17
NOPAT to Interest Expense
1.66 3.40 2.41 4.78 -3.85 6.81 3.94 4.59 5.20 6.14 4.92
EBIT Less CapEx to Interest Expense
1.86 3.29 2.10 4.95 -0.96 13.90 4.14 4.73 11.43 6.04 4.90
NOPAT Less CapEx to Interest Expense
1.67 3.36 2.32 5.01 -2.87 13.13 3.59 4.35 7.83 5.86 4.64
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
215.06% 197.17% 186.20% 156.93% 138.45% 118.72% 98.04% 91.58% 82.76% 85.71% 88.22%
Augmented Payout Ratio
215.06% 197.17% 186.20% 156.93% 138.45% 118.72% 98.04% 91.58% 82.76% 85.71% 88.22%

Financials Breakdown Chart

Key Financial Trends

CareTrust REIT (NYSE: CTRE) showed strong operating momentum in the latest quarter, with revenue, net income and operating cash flow all rising year over year. However, the balance sheet also reflects a much larger asset base and a meaningful increase in leverage, so investors should weigh the company’s growth against its financing needs and dividend coverage.

  • Revenue growth remains solid. Q1 2026 operating revenue rose to $120.8 million, up from $110.4 million in Q4 2025 and $74.5 million in Q1 2025.
  • Net income improved year over year. Common shareholder earnings in Q1 2026 were $80.2 million, versus $65.8 million in Q1 2025.
  • Operating cash flow was strong. CTRE generated $90.4 million of cash from operations in Q1 2026, versus $71.4 million a year earlier.
  • Core profitability remains healthy. Q1 2026 operating income was $71.0 million, indicating the portfolio is still producing meaningful margin after operating expenses.
  • Dividend coverage appears manageable on an earnings basis. Q1 2026 EPS was $0.36 and the cash dividend was $0.39 per share, showing the payout is close to earnings power, though not dramatically covered by GAAP earnings alone.
  • Common equity expanded significantly. Total common equity reached $4.13 billion in Q1 2026, up from $3.30 billion at Q2 2025 and $2.93 billion at Q1 2025.
  • The company continued to access capital. CTRE issued $128.0 million of common equity in Q1 2026 and raised additional debt/investment capital in prior quarters, supporting acquisitions and growth.
  • Asset growth has been dramatic over the last year. Total assets climbed to $5.24 billion in Q1 2026 from $3.88 billion in Q1 2025, reflecting aggressive expansion rather than organic balance-sheet stability alone.
  • Acquisition-driven growth is evident. The cash flow statements show repeated acquisition spending and large investment activity, which can boost long-term earnings but also adds execution risk.
  • Leverage increased sharply. Long-term debt rose to $894.6 million in Q1 2026 from $822.1 million in Q1 2025 and was much lower earlier in the period, suggesting a more levered capital structure.
  • Cash balance fell materially from the prior quarter. Cash and equivalents dropped to $223.2 million in Q1 2026 from $712.5 million in Q3 2025, indicating that cash was deployed for deals, investments, or financing needs.
  • Interest expense remains a meaningful drag. Q1 2026 interest expense was $11.2 million, which continues to absorb a sizeable portion of operating income.
  • Cash flow volatility is high. Net cash from investing swung sharply quarter to quarter because of acquisitions and investment activity, making near-term cash generation less predictable.

Bottom line: CTRE’s latest quarter points to a business that is still growing, generating healthy operating cash flow, and expanding its equity base. The main caution is the company’s heavier use of debt and acquisition-driven investing, which can help scale the portfolio but also raises risk if financing conditions tighten or acquisition returns disappoint.

08/24/26 01:30 AM ETAI Generated. May Contain Errors.

CareTrust REIT Financials - Frequently Asked Questions

According to the most recent income statement we have on file, CareTrust REIT's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

CareTrust REIT's net income appears to be on an upward trend, with a most recent value of $320.29 million in 2025, rising from $10.03 million in 2015. The previous period was $124.40 million in 2024. Check out CareTrust REIT's forecast to explore projected trends and price targets.

CareTrust REIT's total operating income in 2025 was $218.16 million, based on the following breakdown:
  • Total Gross Profit: $380.91 million
  • Total Operating Expenses: $162.75 million

Over the last 10 years, CareTrust REIT's total revenue changed from $73.99 million in 2015 to $380.91 million in 2025, a change of 414.8%.

CareTrust REIT's total liabilities were at $1.09 billion at the end of 2025, a 114.6% increase from 2024, and a 165.2% increase since 2015.

In the past 10 years, CareTrust REIT's cash and equivalents has ranged from $6.91 million in 2017 to $294.45 million in 2023, and is currently $198.04 million as of their latest financial filing in 2025.

Over the last 10 years, CareTrust REIT's book value per share changed from 5.45 in 2015 to 18.07 in 2025, a change of 231.7%.



Financial statements for NYSE:CTRE last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners